DRKS00024722已完成不适用
cfDNA as a predictive marker for the prognosis of severe courses in patients with influenza-like symptoms with and without SARS-CoV-2 infections in General Practice: A prospective cohort study.
Institut für Allgemeinmedizin, Universitätsklinikum Essen0 个研究点目标入组 74 人开始时间: 2021年3月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 74
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 99 Years（—）
- 性别
- All
入选标准
- •Presence of symptoms of a flu infection.
- •Consent for blood draw, oropharyngeal or naso-pharyngeal swab for a rapid SARS-CoV-2 antigen test, subsequent PCR if necessary, and completion of a questionnaire.
排除标准
- •Severe acute or chronic disease with known elevated cfDNA levels based on disease (including tumor disease, severe renal insufficiency, severe/moderate inflammation based on preexisting disease).
- •Lack of German language skills
研究者
相似试验
已完成
不适用
Cell-free DNA as a prognostic biomarker in patients with COVID-19 diseasecfDNA in patients with COVID-19DRKS00031641niversitätsmedizin Mainz72
已完成
不适用
forecasting capacity of Circulating Free DNA to assess treatment results in Patients with Oral CancerCTRI/2019/03/018136RMLIMS30
招募中
不适用
Evaluation of ctDNA as a prognostic marker in gastric cancer or adenocarcinomas of the gastroesophageal junction - a prospective observational studyC16Malignant neoplasm of stomachDRKS00028259niversitätsklinikum Ulm10
尚未招募
不适用
Analysis for the prediction of systemic therapies in patients with locally advanced hepatocellular carcinomaNeoplasmsKCT0004206Seoul National University Hospital400
招募中
不适用
Identification of biomarkers in patients with malignant pleural mesothelioma undergoing chemotherapyACTRN12614000027617Asbestos Diseases Research Institute130